A simple method for preparing synthetic controls for conventional and real-time PCR for the identification of endemic and exotic disease agents

被引:23
作者
Smith, Greg
Smith, Ina
Harrower, Bruce
Warrilow, David
Bletchly, Cheryl
机构
[1] Ctr Publ Hlth Sci, Queensland Hlth Sci Serv, Brisbane, Qld 4108, Australia
[2] Royal Childrens Hosp, Sir Albert Sakzewski Virus Res Ctr, Herston, Qld 4029, Australia
[3] PO Royal Brisbane Hosp, Queensland Inst Med Res, Herston, Qld 4029, Australia
关键词
synthetic control; TaqMan; PCR;
D O I
10.1016/j.jviromet.2006.03.007
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Medical and veterinary diagnostic and public health laboratories world-wide are increasingly being called upon to introduce molecular diagnostic tests for both endemic and exotic diseases. This demand has accelerated following increasing terrorism fears. Ironically these same concerns have lead to tightening of both import and export controls preventing many laboratories, particularly those outside of the United States, from gaining access to positive control material. This in turn has prevented many laboratories from introducing much needed molecular diagnostic tests. We describe here a generic approach for preparing synthetic DNA or RNA control material for use in either TaqMan or conventional PCR assays. The production of synthetic controls using this approach does not require cloning or special equipment or facilities beyond that found in any laboratory performing molecular diagnostics. The approach significantly reduces the possibility of contamination or erroneously reporting false-positive reactions due to contamination from positive control material. Synthetic controls produced using this approach have been employed in all molecular diagnostic tests performed in our laboratory and are used irrespective of whether we possess the organism or not. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:229 / 234
页数:6
相关论文
共 14 条
[1]  
Aslanzadeh J, 2004, ANN CLIN LAB SCI, V34, P389
[2]   False-positive results and contamination in nucleic acid amplification assays: Suggestions for a prevent and destroy strategy [J].
Borst, A ;
Box, ATA ;
Fluit, AC .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (04) :289-299
[3]   Identification of a novel coronavirus in patients with severe acute respiratory syndrome [J].
Drosten, C ;
Günther, S ;
Preiser, W ;
van der Werf, S ;
Brodt, HR ;
Becker, S ;
Rabenau, H ;
Panning, M ;
Kolesnikova, L ;
Fouchier, RAM ;
Berger, A ;
Burguière, AM ;
Cinatl, J ;
Eickmann, M ;
Escriou, N ;
Grywna, K ;
Kramme, S ;
Manuguerra, JC ;
Müller, S ;
Rickerts, V ;
Stürmer, M ;
Vieth, S ;
Klenk, HD ;
Osterhaus, ADME ;
Schmitz, H ;
Doerr, HW .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) :1967-1976
[4]  
Frank Erica, 2005, BMJ, V331, pE378, DOI 10.1136/bmj.331.7517.E378
[5]   FALSE-POSITIVE POLYMERASE CHAIN-REACTION RESULTS IN THE DIAGNOSIS OF HERPES-SIMPLEX ENCEPHALITIS [J].
LANDRY, ML .
JOURNAL OF INFECTIOUS DISEASES, 1995, 172 (06) :1641-1643
[6]   Performance and cost evaluation of one commercial and six in-house conventional and real-time reverse transcription-PCR assays for detection of severe acute respiratory syndrome coronavirus [J].
Mahony, JB ;
Petrich, A ;
Louie, L ;
Song, XY ;
Chong, S ;
Smieja, M ;
Chernesky, M ;
Loeb, M ;
Richardson, S .
JOURNAL OF CLINICAL MICROBIOLOGY, 2004, 42 (04) :1471-1476
[7]   Risk assessment models and contamination management: Implications for broad-range ribosomal DNA PCR as a diagnostic tool in medical bacteriology [J].
Millar, BC ;
Xu, JR ;
Moore, JE .
JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (05) :1575-1580
[8]  
PERKINELMER, 1998, TAQMAN UNIVERSAL PCR
[9]  
Rotz L D, 2000, J Public Health Manag Pract, V6, P45
[10]   Public health assessment of potential biological terrorism agents [J].
Rotz, LD ;
Khan, AS ;
Lillibridge, SR ;
Ostroff, SM ;
Hughes, JM .
EMERGING INFECTIOUS DISEASES, 2002, 8 (02) :225-230